A Single Arm Phase II Study with Safety Run-in of Peptide Receptor Radionuclide Therapy (PRRT) in Combination with Immunotherapy for Patients with Merkel Cell Cancer (iPRRT Study)

Status: Open to Accrual 

Learn more: 

• https://clinicaltrials.gov/study/NCT05583708

Study Contact: studies@hoosiercancer.org; (317) 921-2050.